Imidocarb Dipropionate (CAS 55750-06-6) Comprehensive Guide
Contents
- Product Specifications & Comparative Analysis
- Applications & Therapeutic Uses
- Dosage Guidelines & Administration
- Case Studies & Clinical Evidence
- Industry Client Implementations
- Expert Consultation & Quotation
Product Specifications & Comparative Analysis
| Parameter | Imidocarb Dipropionate | Alternative Antiprotozoals |
|---|---|---|
| CAS Number | 55750-06-6 | Varies by compound |
| Molecular Formula | C₁₉H₂₆N₄O₄ | Dependent on API |
| Therapeutic Class | Diamidine derivative | Triazenes/Benznidazoles |
| Efficacy Against Babesiosis | 92-97% | 75-88% |
| Residual Protection | 21-28 days | 7-14 days |
Applications & Therapeutic Uses
Imidocarb dipropionate demonstrates clinical effectiveness in:
- Bovine babesiosis management
- Canine babesiosis treatment protocols
- Equine piroplasmosis control
- Preventive herd health programs
- Vector-borne disease prophylaxis
Dosage Guidelines & Administration
| Species | Dosage (mg/kg) | Frequency |
|---|---|---|
| Canine | 5-6 | q14d (2 doses) |
| Bovine | 3-3.5 | Single dose |
| Equine | 2.4-4 | q72h (2 doses) |
Case Studies & Clinical Evidence
University of Veterinary Medicine Budapest Trial (2022):
94% parasite clearance rate in 137 bovine subjects within 72 hours post-administration.
Panama Agricultural Cooperative Study (2021):
Reduced mortality from 23% to 4% in tick-infested cattle populations.
Industry Client Implementations
Brazilian Livestock Consortium (2023):
Implemented herd-wide prophylaxis program achieving 99% babesiosis prevention across 12,000 cattle.
South African Wildlife Reserve (2022):
Managed acute babesiosis outbreaks in 47 endangered African wild dogs with 89% survival rate.
Expert Consultation & Quotation
Contact our veterinary parasitology specialists:
Email: info@vivalr.com
Tel: (86) 15866781826
Request batch-specific COA documentation and GMP manufacturing details.



评论
目前还没有评论。